Recent news on Gallium Nitrate

Genta Incorporated to Present Multiple Abstracts at the Annual ...  -  25 May 2007
Earthtimes.orgThe lead drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for treatment

Genta Announces New Phase 3 Trial of Genasense(R) in Patients with ...  -  Apr 18, 2007
PR Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta and IDIS Announce Global Ex-US Agreement for Named Patient ...  -  27 Mar 2007
Drug Newswire (press release),...oncology products, Ganite(R) (gallium nitrate injection) and Genasense(R) (oblimersen sodium) Injection, on a named patient/compassionate use basis.

Bacterial Bait and Switch: Germs Tricked into Absorbing Wrong Element  -  Mar 19, 2007
Scientific AmericanThe team observed that small concentrations of gallium—mixed with nitric acid to become gallium nitrate in test tubes—could inhibit the growth of

Genta Announces Expectation of a Negative Opinion from the CHMP on ...  -  Mar 23, 2007
PR Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Epiphany's Series A Adds $36M For Infectious Disease Pipeline  -  Mar 15, 2007
BioWorld Online,...including product sales from the named-patient distribution programs for Ganite (gallium nitrate injection) in cancer-related hypercalcemia and

Phase 2 Results Of Genasense(R) Plus Chemotherapy In Advanced ...  -  Feb 24, 2007
Medical News Today (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta Incorporated Announces Fourth Quarter and Year End 2006 ...  -  Feb 13, 2007
Insurance News Net,The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta Incorporated Announces Fourth Quarter and Year End 2006 ...  -  Feb 15, 2007
Drug Newswire (press release),...with Emisphere Technologies, Inc. on the development of an oral formulation of its currently marketed product, Ganite(R) (gallium nitrate injection).

Genta Restructures Operations to Focus on Future Initiatives  -  18 Jan 2007
Drug Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Novel gallium compound offers treatment for lymphoma patients with ...  -  Dec 11, 2006
SpiritIndia,Although the cellular basis for tumor cell resistance to gallium nitrate is not well understood, gallium maltolate appears to be a unique gallium

Cancer-fighting agent heads for clinical trials  -  Dec 7, 2006
WTN News,Clinical trials will begin in the near future to see if the compound, Titan Pharmaceutical's gallium maltolate, is a viable alternative to gallium nitrate

Genta Restructures Operations to Focus on Future Initiatives  -  Dec 20, 2006
Drug Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the US for

Genta Clinical Programs Featured in Presentations at Annual ...  -  Dec 4, 2006
PR Newswire (press release),The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the company is exclusively marketing in the US for

Genta Clinical Programs Featured in Presentations at Annual ...  -  Dec 4, 2006
Yahoo! News (press release)The leading drug in Genta's small molecule program is Ganite® (gallium nitrate injection), which the company is exclusively marketing in the US for

Genta Initiates Pilot Clinical Trial of Genasense® Plus Abraxane ...  -  Nov 30, 2006
PipelineReview.com (press release),The leading drug in Genta's small molecule program is Ganite® (gallium nitrate injection), which the Company is exclusively marketing in the US for

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional